Biotech Values

[jq1234]

>> They estimated that 70% of Sovaldi sales were for Olysio/Sovaldi combinations.

Before you answer those questions, how accurate are those estimates? It doesn't seem these estimates match with Olysio revenue reported by JNJ unless JNJ has been discounting Olysio heavily like 50%. Is there any evidence JNJ has been doing that? For 1Q, Olysio revenue was consistent with reported percentage of Sovaldi/Olysio usage off label. For 2Q, those revenue numbers are way off.